Tim Ikeda
Papers
1
Total Citations
22
H-Index
1
About
Tim Ikeda has been a pivotal figure in the advancement of high-throughput screening and assay technologies, with a primary focus on acoustic droplet ejection (ADE) for cell-based assays. His landmark 2015 paper, "Implementation and Challenges of Direct Acoustic Dosing into Cell-Based Assays," has garnered 22 citations and documents the transformative adoption of Labcyte Echo ADE technology at AstraZeneca since 2005. Ikeda’s work addresses the critical challenges of directly dosing compounds into cell-based assays, a technique that has become the gold standard across AstraZeneca’s global research and development operations. By detailing the implementation hurdles and solutions, he enabled more precise, contactless compound transfer, significantly improving assay reproducibility and throughput. His contributions have not only streamlined drug discovery workflows but also set a benchmark for integrating acoustic technology into cellular systems, influencing both academic and industrial labs. Ikeda’s research underscores the importance of marrying engineering innovation with biological application, making him a key architect of modern screening methodologies.
Research Focus
Key Achievements
Top Papers
- 1